Notably, HIF-1α/Adora2b co-activation synergistically upregulates VEGF and TGF-β through a HIF-1α/CREB complex binding their promoters, driving angiogenesis and fibrosis—hallmarks of GC progression (54, 65). This evidence concerns the gene ADORA2B and gastric cancer.